Glenmark Pharmaceuticals Inc, USA, a unit of the company, has received tentative approval from the US Food Drug Administration (US FDA) for Saxagliptin Tablets in strengths of 2.5 mg and 5 mg, the Mumbai-based drug maker said in a statement.
Glenmark Pharmaceuticals Inc, USA, a unit of the company, has received tentative approval from the US Food Drug Administration (US FDA) for Saxagliptin Tablets in strengths of 2.5 mg and 5 mg, the Mumbai-based drug maker said in a statement. Glenmark Pharmaceuticals Inc, USA, a unit of the company, has received tentative approval from the US Food Drug Administration (US FDA) for Saxagliptin Tablets in strengths of 2.5 mg and 5 mg, the Mumbai-based drug maker said in a statement. Moneycontrol Latest News Read More
English 
हिन्दी